Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions

Nawab John Dar; Shahnawaz Ali Bhat; Muneeb U Rehman; Anthony Booker

doi:10.3389/fphar.2023.1187334

Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions

Front Pharmacol. 2023 May 2:14:1187334. doi: 10.3389/fphar.2023.1187334. eCollection 2023.

Authors

Nawab John Dar¹, Shahnawaz Ali Bhat², Muneeb U Rehman³, Anthony Booker⁴

Affiliations

¹ School of Medicine, UT Health, San Antonio, TX, United States.
² Department of Zoology, FoLS, Aligarh Muslim University, Aligarh, India.
³ School of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
⁴ School of Life Sciences, University of Westminster, London, United Kingdom.

No abstract available

Keywords: Withania somnifera (Ashwagandha); anti-cancer (anticancer) drugs; anti-infammatory activity; natural products (NP); neuroprotection; pharmacological action; withanolide (PubChem CID: 161671); withanolides.

Publication types

Editorial